Palantir Is a ‘Trillion-Dollar’ Story, Even at This Valuation, Says Dan Ives after Blowout Q2

Palantir Technologies (PLTR) stock rose over 4% after reporting better-than-expected Q2 results, with revenue hitting $1 billion for the first time, and significantly raising its full-year 2025 revenue and profitability guidance, driven by strong demand for its AI platform. Wedbush analyst Dan Ives reiterated an Outperform rating and $160 price target, citing a "blowout" quarter and calling PLTR a top tech pick due to accelerating AI adoption, particularly an expected 85% rise in US commercial revenue. However, Wall Street's broader consensus remains a "Hold" with an average price target of $111.14, implying over 30% downside risk from current levels despite the positive update.

Analysis

Palantir Technologies (PLTR) reported a strong second quarter, surpassing a key milestone with quarterly revenue exceeding $1 billion for the first time, beating analyst estimates of $940 million. More significantly, the company issued a substantial upward revision to its full-year 2025 guidance. Revenue forecasts were raised to a range of $4.142 billion to $4.150 billion, and adjusted operating income guidance was increased to between $1.912 billion and $1.920 billion. This positive outlook is attributed to accelerating demand for its Artificial Intelligence Platform (AIP), particularly within the U.S. commercial sector, where revenue growth is now projected at 85% year-over-year, a sharp increase from the previous 68% forecast. While Wedbush analyst Dan Ives described the results as a "blowout" and reiterated a $160 price target, dismissing valuation concerns, this bullish stance is not reflective of the broader market sentiment. The Wall Street consensus remains a "Hold," based on a mix of four Buy, seven Hold, and three Sell ratings, with an average price target of $111.14 that implies a significant 30.82% downside from current levels, highlighting a major disconnect between the company's operational momentum and prevailing valuation concerns among analysts.

Key Decisions for Investors

• Investors with a growth-oriented thesis may view the significantly raised guidance and accelerating 85% U.S. commercial revenue growth as a strong signal to maintain or add to positions, aligning with the bullish view that operational execution justifies the premium valuation.
• Conversely, the consensus analyst price target, which implies over 30% downside risk, should serve as a major point of caution, suggesting the market may believe the positive outlook is already more than fully priced into the stock.
• Monitor future performance of the U.S. commercial segment closely, as its continued high growth is the primary justification for the company's optimistic guidance and is critical for validating the bull case against broader market skepticism.
• Given the stark divergence between the single bullish analyst target of $160 and the cautious consensus, investors should anticipate heightened stock volatility and manage position size accordingly to mitigate risk.